ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses

June 13, 1986

Senate Committee Proposes $301 Million Increase For NIH

September 22, 1995

In Brief: NCI-Litton Negations On Frederick continue; Staffs Not Worried About Possible GAO Probe

July 15, 1977

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995

Brain Gliomas Progress When Gene Function Is Lost

April 25, 2003

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

February 15, 2002